Latest

phosphorylated tau

Image shows positive α-Synuclein staining of a Lewy body in a patient with Parkinson's disease.

·February 17, 2016·4 min read

Biomarker for Early Cognitive Decline in Parkinson’s Disease Identified

A new study reports lower concentrations of α-synuclein in the cerebrospinal fluid of Parkinson's patients is associated with reduced cognitive performance.

This image shows a brain slice of a person with alzheimer's.

Featured Neurology

·July 15, 2015·7 min read

Antibody Therapy Can Treat TBI and Reduce Alzheimer’s Risk

According to researchers, a new antibody therapy can help treat TBI and prevent the associated development of Alzheimer's disease and CTE.

Featured Genetics

·May 2, 2014·2 min read

Study Explores Genetics Behind Alzheimer’s Resiliency

Researchers discover a potential genetic variant which could make the brain more resilient to Alzheimer's disease.

this shows the neuronal changes in alzheimers.

Featured Neurology Open Neuroscience Articles

·March 18, 2014·3 min read

How Age Opens the Gates for Alzheimer’s

Researchers discover why aging and molecular changes in brain circuitry can lead to tangles associated with AD.

The image shows the tau proteins associated with Alzheimer's disease.

Featured Neurology

·June 19, 2013·3 min read

New Alzheimer’s Research Suggests Possible Cause: The Interaction of Proteins in the Brain

Researchers discover by looking at amyloid-beta and tau independently that the interaction between the proteins could be the key to the cognitive decline associated with Alzheimer's disease. As the interaction between the two proteins increased, the progression of Alzheimer's worsened.